Cargando…

A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold

The reported incidence of COVID-19-associated pulmonary aspergillosis (CAPA) ranges between 2.4% and 35% in intensive care unit (ICU) patients, and awareness in the medical community is rising. We performed a regional retrospective observational study including patients diagnosed with CAPA defined a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lupia, Tommaso, Montrucchio, Giorgia, Gaviraghi, Alberto, Musso, Gaia, Puppo, Mattia, Bolla, Cesare, Shbaklo, Nour, Rizzello, Barbara, Della Selva, Andrea, Concialdi, Erika, Rumbolo, Francesca, Barbui, Anna Maria, Brazzi, Luca, De Rosa, Francesco Giuseppe, Corcione, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785727/ https://www.ncbi.nlm.nih.gov/pubmed/36547597 http://dx.doi.org/10.3390/jof8121264

Ejemplares similares

Meropenem/Vaborbactam and Cefiderocol as Combination or Monotherapy to Treat Multi-Drug Resistant Gram-Negative Infections: A Regional Cross-Sectional Survey from Piedmont Infectious Disease Unit Network (PIDUN)
por: Lupia, Tommaso, et al.
Publicado: (2022)

Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements
por: Montrucchio, G., et al.
Publicado: (2021)

Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with?
por: Corcione, Silvia, et al.
Publicado: (2023)

Legionella pneumophila Infections during a 7-Year Retrospective Analysis (2016–2022): Epidemiological, Clinical Features and Outcomes in Patients with Legionnaires’ Disease
por: Lupia, Tommaso, et al.
Publicado: (2023)

COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Dimopoulos, George, et al.
Publicado: (2021)

Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study
por: Corcione, Silvia, et al.
Publicado: (2021)

Infection Control in the Era of COVID-19: A Narrative Review
por: Shbaklo, Nour, et al.
Publicado: (2021)

Two cases of COVID‐19‐associated pulmonary aspergillosis (CAPA)
por: Lim, Jin Lee, et al.
Publicado: (2022)

Prognostic Value of Mid-Regional Proadrenomedullin Sampled at Presentation and after 72 Hours in Septic Patients Presenting to the Emergency Department: An Observational Two-Center Study
por: Bima, Paolo, et al.
Publicado: (2022)

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020)

COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report
por: Sharma, Avinash, et al.
Publicado: (2020)

COVID-19 associated pulmonary aspergillosis (CAPA) in a pregnant woman
por: Agrawal, Shruti, et al.
Publicado: (2021)

THE PANDEMIC'S FUNGAL REVENGE: COVID-19 ASSOCIATED PULMONARY ASPERGILLOSIS (CAPA)
por: PATEL, AZAD, et al.
Publicado: (2022)

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2021)

First Cases of Candida auris in a Referral Intensive Care Unit in Piedmont Region, Italy
por: Corcione, Silvia, et al.
Publicado: (2022)

Proadrenomedullin in the Management of COVID-19 Critically Ill Patients in Intensive Care Unit: A Systematic Review and Meta-Analysis of Evidence and Uncertainties in Existing Literature
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Trichoderma spp.-Related Pneumonia: A Case Report in Heart–Lung Transplantation Recipient and a Systematic Literature Review
por: Burzio, Carlo, et al.
Publicado: (2023)

Pneumocystis jirovecii Pneumonia after Heart Transplantation: Two Case Reports and a Review of the Literature
por: Burzio, Carlo, et al.
Publicado: (2023)

COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
por: Fekkar, Arnaud, et al.
Publicado: (2021)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021)

P20 COVID-19-associated pulmonary aspergillosis (CAPA): review of utility of local CAPA guideline and MDT in directing diagnosis and antifungal stewardship
por: Hawkins, Lois, et al.
Publicado: (2022)

Bacterial and Viral Infections in Liver Transplantation: New Insights from Clinical and Surgical Perspectives
por: Shbaklo, Nour, et al.
Publicado: (2022)

COVID-19: in the uncertainty, do not try this at home
por: Lupia, Tommaso, et al.
Publicado: (2020)

Role of Oritavancin in the Treatment of Infective Endocarditis, Catheter- or Device-Related Infections, Bloodstream Infections, and Bone and Prosthetic Joint Infections in Humans: Narrative Review and Possible Developments
por: Lupia, Tommaso, et al.
Publicado: (2023)

The CAPA!
por: Staff Association
Publicado: (2016)

The CAPA!
por: Staff Association
Publicado: (2021)

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
por: Bentvelsen, Robbert G., et al.
Publicado: (2022)

P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)

P170 Life threatening hemoptysis in COVID-19 associated Pulmonary Aspergillosis (CAPA)
por: Soman, Rajeev, et al.
Publicado: (2022)

405. Incidence and Potential Risk Factors of COVID-19 Associated Pulmonary Aspergillosis (CAPA)
por: Imoto, Waki, et al.
Publicado: (2023)

Strongyloides spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin Lymphoma
por: Lupia, Tommaso, et al.
Publicado: (2023)

Overlapping Infection by Strongyloides spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the Literature
por: Lupia, Tommaso, et al.
Publicado: (2023)

Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
por: Lupia, Tommaso, et al.
Publicado: (2022)

Antimicrobial Prophylaxis in Extracorporeal Membrane Oxygenation: Is the Debate Still Open?
por: Montrucchio, Giorgia, et al.
Publicado: (2022)

Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review
por: Chong, W.H., et al.
Publicado: (2021)

Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Ruiz-Ruigómez, María, et al.
Publicado: (2022)

COVID-19-associated pulmonary aspergillosis (CAPA) might be associated with increased risk for pneumopleural fistula
por: Naendrup, Jan-Hendrik, et al.
Publicado: (2023)

Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis – CAPA
por: Cocio, Tiago Alexandre, et al.
Publicado: (2023)

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study
por: Montrucchio, Giorgia, et al.
Publicado: (2023)

Real-Life Experience of Molnupiravir in Hospitalized Patients Who Developed SARS-CoV2-Infection: Preliminary Results from CORACLE Registry
por: Lupia, Tommaso, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l4fpmalt3av1o3flbqmrdrfd55